U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Tuesday. Here are some big stocks recording gains in today’s session.
- iCoreConnect Inc. ICCT shares jumped 70.4% to $2.7089 after dipping 20% on Monday.
- Big Lots, Inc. BIG rose 23.3% to $7.78 following better-than-expected quarterly results.
- Globalstar, Inc. GSAT surged 21% to $1.2850 after the company announced it appointed Dr. Paul Jacobs as CEO and announced an agreement to license XCOM Labs technology.
- UP Fintech Holding Limited TIGR rose 20.3% to $4.3450 following strong quarterly results.
- PDD Holdings Inc. PDD jumped 17.5% to $94.86 after the company reported upbeat second-quarter results.
- Goosehead Insurance, Inc GSHD gained 17% to $69.64. Goosehead Insurance will replace NuVasive Inc in the S&P SmallCap 600, effective Sept. 1.
- Taysha Gene Therapies, Inc. TSHA gained 17% to $2.79. Taysha Gene Therapies received written notice from the Nasdaq informing the company that it had regained compliance.
- Ginkgo Bioworks Holdings, Inc. DNA climbed 17% to $2.09 after the company and Google Cloud announced a five-year strategic cloud and AI partnership, intended to enable Ginkgo to develop and deploy AI tools for biology and biosecurity.
- Inhibrx, Inc. INBX jumped 15% to $22.25. Inhibrx announced a $200 million private placement financing.
- KE Holdings Inc. BEKE gained 11.5% to $16.45.
- Gravity Co., Ltd. GRVY climbed 11.4% to $76.86.
- NovoCure Limited NVCR gained 9.4% to $20.37. Wells Fargo analyst Larry Biegelsen maintained NovoCure with a Overweight and lowered the price target from $102 to $49.
- Aclaris Therapeutics, Inc. ACRS surged 9.4% to $7.22. Aclaris Therapeutics Chief Business Officer James Loerop bought a total of 14,705 shares at an average price of $6.80.
- Jackson Financial Inc. JXN climbed 9.3% to $37.87. Jackson Financial Inc. will replace NexTier Oilfield Solutions in the S&P SmallCap 600.
- Chico's FAS, Inc. CHS gained 9.1% to $5.59 following strong quarterly earnings.
- Futu Holdings Limited FUTU rose 8.8% to $59.82.
- Opera Limited OPRA climbed 6.6% to $14.52.
- BeiGene, Ltd. BGNE gained 6.6% to $215.24. Morgan Stanley maintained BeiGene with an Overweight and lowered the price target from $321 to $319.
- AlloVir, Inc. ALVR rose 5.1% to $3.3750.
Read More: Verizon To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Tuesday
Loading...
Loading...
ACRSAclaris Therapeutics Inc
$1.824.00%
Edge Rankings
Momentum
66.10
Growth
N/A
Quality
N/A
Value
52.90
Price Trend
Short
Medium
Long
BEKEKE Holdings Inc
$18.611.53%
DNAGinkgo Bioworks Holdings Inc
$12.718.08%
FUTUFutu Holdings Ltd
$191.105.90%
GRVYGRAVITY Co Ltd
$69.008.03%
GSATGlobalstar Inc
$26.653.66%
GSHDGoosehead Insurance Inc
$89.493.36%
ICCTiCoreConnect Inc
$0.0200-98.9%
INBXInhibrx Biosciences Inc
$25.003.48%
JXNJackson Financial Inc
$98.473.17%
NVCRNovoCure Ltd
$12.424.28%
OPRAOpera Ltd
$16.060.12%
PDDPDD Holdings Inc
$127.833.96%
TIGRUP Fintech Holding Ltd
$12.8414.3%
TSHATaysha Gene Therapies Inc
$3.056.27%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.